IGF1 and chronic kidney disease: In the analyses of muscle biopsies from patients with CKD, the most consistent alterations in expression levels are the reductions in IGF1, whereas elevations in atrogenes, such as atrogin1, MuRF1, and myostatin, are less consistent throughout the different studies [74,112,113,114,119,120].